| RSS
Business center
Office
Post trade leads
Post
Rank promotion
Ranking
 
You are at: Home » News » International »

Mainstream psoriasis drugs marketed in the world

Increase font size  Decrease font size Date:2019-07-11   Views:23

Pharmaceutical product name

Trade name

Company

Target

FDA/NMPA approval time

Ustekinumab

Stelara

J & J

IL-12/23

2009/2019

Tildrakizumab

Ilumya

MSD, Sun Pharmaceutical

IL-23

2018

Certolizumab

Cimzia

UCB

TNF-ɑ

2008

Guselkumab

Tremfya

J & J

IL-23

2017

Secukinumab

Cosentyx

Novartis

IL-17A

2015/2019

Ixekizumab

Taltz

Eli Lilly

IL-17A

2017

Brodalumab

Siliq

Valeant

IL-17R

2017

Apremilast

Otezla

Celgene

PDE-4

2014

 
 
[ Search ]  [ ]  [ Email ]  [ Print ]  [ Close ]  [ Top ]

 
Total:0comment(s) [View All]  Related comment

 
Recomment
Popular
 
 
Home | About | Service | copyright | agreement | contact | about | SiteMap | Links | GuestBook | Ads service | 京ICP 68975478-1
Tel:+86-10-68645975           Fax:+86-10-68645973
E-mail:yaoshang68@163.com     QQ:1483838028